ICLO | IGBH | ICLO / IGBH | |
Gain YTD | 2.536 | 1.007 | 252% |
Net Assets | 315M | 101M | 312% |
Total Expense Ratio | 0.19 | 0.14 | 136% |
Turnover | 53.00 | 13.00 | 408% |
Yield | 6.13 | 6.87 | 89% |
Fund Existence | 3 years | 10 years | - |
ICLO | IGBH | |
---|---|---|
RSI ODDS (%) | N/A | 2 days ago27% |
Stochastic ODDS (%) | 2 days ago4% | 2 days ago70% |
Momentum ODDS (%) | N/A | 2 days ago46% |
MACD ODDS (%) | 2 days ago17% | 2 days ago49% |
TrendWeek ODDS (%) | 2 days ago19% | 2 days ago48% |
TrendMonth ODDS (%) | 2 days ago16% | 2 days ago64% |
Advances ODDS (%) | 2 days ago22% | 15 days ago64% |
Declines ODDS (%) | 7 days ago23% | 9 days ago46% |
BollingerBands ODDS (%) | N/A | 2 days ago59% |
Aroon ODDS (%) | 2 days ago15% | 2 days ago65% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYAVX | 72.66 | N/A | N/A |
Rydex S&P MidCap 400 Pure Value H | |||
MIDFX | 58.56 | N/A | N/A |
Marsico Midcap Growth Focus Instl | |||
PHLAX | 32.36 | N/A | N/A |
PGIM Jennison Health Sciences A | |||
BROIX | 22.19 | N/A | N/A |
BlackRock Advantage International Instl | |||
MECFX | 15.51 | -0.05 | -0.32% |
NYLI Epoch Capital Growth Class I |